CATXPerspective Therapeutics, Inc.
$2.71-22% 1Y
$2.71
$2.0552 weeks$5.65
CATX in its own filings
CATX's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
513
Events found in the filings · across 1,140 filings · the record starts in 1995
- Hard flags
- 3
Hard flags
- Most recent filing
- Oct 8, 2026
Most recent filing · Form 8-K
- Record starts
- Aug 22, 1995
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 9, 2026
- Restatement admitted (non-reliance)historical
- 2006-05-09
- Change in certifying accountant2 occurrences
- 2024-04-08
- Late periodic report8 occurrences
- 2006-05-15
- SEC comment-letter activity27 occurrences
- 2024-04-08
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 8, 2026On October 8, 2026, Perspective Therapeutics, Inc. issued a press release announcing that the U.S. Food and Drug Administration granted Fast Track Designation for the development of PSV359 for adult patients with locally advanced unresectable and/or metastatic fibroblast activation protein-positive solitary fibrous …Other event · Form 8-K
- Oct 1, 2026On October 1, 2026, Perspective Therapeutics, Inc. updated its corporate presentation.Other event · Form 8-K
- Sep 14, 2026On September 14, 2026, Perspective Therapeutics, Inc. issued a press release announcing a clinical collaboration and supply agreement with Merck.Other event · Form 8-K
- Sep 8, 2026On September 8, 2026, Perspective Therapeutics, Inc. updated its corporate presentation.Other event · Form 8-K
- Aug 10, 2026Also on August 10, 2026, the Company posted an updated corporate presentation to its website at www.perspectivetherapeutics.com.Earnings release · Form 8-K
- Aug 3, 2026On August 3, 2026, Perspective Therapeutics, Inc. updated its corporate presentation.Other event · Form 8-K
- Jul 1, 2026On July 1, 2026, Perspective Therapeutics, Inc. updated its corporate presentation.Other event · Form 8-K
- Jun 1, 2026On June 1, 2026, Perspective Therapeutics, Inc. updated its corporate presentation.Other event · Form 8-K
- May 22, 2026On May 21, 2026, Perspective Therapeutics, Inc. issued a press release announcing certain interim results from its ongoing clinical trials that are being presented at the 2026 American Society of Clinical Oncology Annual Meeting taking place May 29-June 2, 2026 in Chicago, Illinois.Other event · Form 8-K
- May 11, 2026Also on May 11, 2026, the Company posted an updated corporate presentation on its website at www.perspectivetherapeutics.com.Earnings release · Form 8-K
- May 4, 2026On May 4, 2026, the Company posted the Presentation to its website.Earnings release · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…